Ridolfi et al., 2013 - Google Patents
The role of the innate immune system in Alzheimer's disease and frontotemporal lobar degeneration: an eye on microgliaRidolfi et al., 2013
View PDF- Document ID
- 1336463535351179066
- Author
- Ridolfi E
- Barone C
- Scarpini E
- Galimberti D
- Publication year
- Publication venue
- Journal of Immunology Research
External Links
Snippet
In the last few years, genetic and biomolecular mechanisms at the basis of Alzheimer's disease (AD) and frontotemporal lobar degeneration (FTLD) have been unraveled. A key role is played by microglia, which represent the immune effector cells in the central nervous …
- 206010001897 Alzheimer's disease 0 title abstract description 71
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ridolfi et al. | The role of the innate immune system in Alzheimer’s disease and frontotemporal lobar degeneration: an eye on microglia | |
| Chang et al. | Tau: Enabler of diverse brain disorders and target of rapidly evolving therapeutic strategies | |
| Gómez-Benito et al. | Modeling Parkinson’s disease with the alpha-synuclein protein | |
| Billings et al. | Learning decreases Aβ* 56 and tau pathology and ameliorates behavioral decline in 3xTg-AD mice | |
| Carter et al. | Astrocyte biomarkers in Alzheimer’s disease | |
| Bachiller et al. | Microglia in neurological diseases: a road map to brain-disease dependent-inflammatory response | |
| Karch et al. | A comprehensive resource for induced pluripotent stem cells from patients with primary tauopathies | |
| Sala Frigerio et al. | Alzheimer's disease mechanisms and emerging roads to novel therapeutics | |
| Lian et al. | Signaling pathways regulating neuron–glia interaction and their implications in Alzheimer's disease | |
| Clavaguera et al. | Brain homogenates from human tauopathies induce tau inclusions in mouse brain | |
| Bell et al. | SH-SY5Y-derived neurons: a human neuronal model system for investigating TAU sorting and neuronal subtype-specific TAU vulnerability | |
| Mullin et al. | Pathogenic mechanisms of neurodegeneration in Parkinson disease | |
| Spires-Jones et al. | Tau pathophysiology in neurodegeneration: a tangled issue | |
| Konishi et al. | Phagocytic astrocytes: emerging from the shadows of microglia | |
| Bodea et al. | Tau physiology and pathomechanisms in frontotemporal lobar degeneration | |
| Xia et al. | Presenilin-1 knockin mice reveal loss-of-function mechanism for familial Alzheimer’s disease | |
| Feng et al. | Deficient neurogenesis in forebrain-specific presenilin-1 knockout mice is associated with reduced clearance of hippocampal memory traces | |
| Rizzini et al. | Tau gene mutation K257T causes a tauopathy similar to Pick's disease | |
| Mandemakers et al. | A cell biological perspective on mitochondrial dysfunction in Parkinson disease and other neurodegenerative diseases | |
| Götz et al. | A decade of tau transgenic animal models and beyond | |
| Wolfe | The role of tau in neurodegenerative diseases and its potential as a therapeutic target | |
| Hutton et al. | Analysis of tauopathies with transgenic mice | |
| Falzone et al. | Axonal stress kinase activation and tau misbehavior induced by kinesin-1 transport defects | |
| Hock et al. | Prion‐like propagation as a pathogenic principle in frontotemporal dementia | |
| Cenini et al. | Dissecting Alzheimer's disease pathogenesis in human 2D and 3D models |